Search Results - "Shi, Jack"
-
1
First-in-Human Phase I Study of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in Patients with Advanced Solid Malignancies
Published in Clinical cancer research (01-07-2017)“…Indoleamine 2,3-dioxygenase-1 (IDO1) catalyzes the degradation of tryptophan to N-formyl-kynurenine. Overexpressed in many solid malignancies, IDO1 can promote…”
Get full text
Journal Article -
2
The pharmacokinetics, pharmacodynamics, and safety of baricitinib, an oral JAK 1/2 inhibitor, in healthy volunteers
Published in Journal of clinical pharmacology (01-12-2014)“…Baricitinib (also known as LY3009104 or INCB028050), a novel and potent small molecule inhibitor of Janus kinase family of enzymes (JAKs) with selectivity for…”
Get full text
Journal Article -
3
Preliminary clinical activity of a topical JAK1/2 inhibitor in the treatment of psoriasis
Published in Journal of the American Academy of Dermatology (01-10-2012)“…Background Janus-associated kinases (JAKs) are involved in signal transduction from a variety of cytokines implicated in the pathogenesis of psoriasis,…”
Get full text
Journal Article -
4
Robustness and the evolution of length control strategies in the T3SS and flagellar hook
Published in Biophysical journal (07-09-2021)“…Bacterial cells construct many structures, such as the flagellar hook and the type III secretion system (T3SS) injectisome, that aid in crucial physiological…”
Get full text
Journal Article -
5
A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)–only epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancer
Published in Gynecologic oncology (01-09-2017)“…Indoleamine 2,3-dioxygenase-1 (IDO1) is a key regulator of immune tolerance in ovarian cancer. This study investigated efficacy and safety of the IDO1 enzyme…”
Get full text
Journal Article -
6
Beyond private 5G networks: applications, architectures, operator models and technological enablers
Published in EURASIP journal on wireless communications and networking (04-12-2021)“…Private networks will play a key role in 5G and beyond to enable smart factories with the required better deployment, operation and flexible usage of available…”
Get full text
Journal Article -
7
The Pharmacokinetics, Pharmacodynamics, and Safety of Orally Dosed INCB018424 Phosphate in Healthy Volunteers
Published in Journal of clinical pharmacology (01-12-2011)“…INCB018424 phosphate, a potent inhibitor of JAK enzymes with selectivity for JAK1&2, is in development for the treatment of myelofibrosis (MF). The oral dose…”
Get full text
Journal Article -
8
In Vitro Interactions of Epacadostat and its Major Metabolites with Human Efflux and Uptake Transporters: Implications for Pharmacokinetics and Drug Interactions
Published in Drug metabolism and disposition (01-06-2017)“…Epacadostat (EPAC) is a first-in-class, orally active inhibitor of the enzyme indoleamine 2,3-dioxygenase 1 and has demonstrated promising clinical activity…”
Get full text
Journal Article -
9
Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050
Published in The Journal of immunology (1950) (01-05-2010)“…Inhibiting signal transduction induced by inflammatory cytokines offers a new approach for the treatment of autoimmune diseases such as rheumatoid arthritis…”
Get full text
Journal Article -
10
Mathematical Model for Length Control by the Timing of Substrate Switching in the Type III Secretion System
Published in PLoS computational biology (01-04-2016)“…Type III Secretion Systems (T3SS) are complex bacterial structures that provide gram-negative pathogens with a unique virulence mechanism whereby they grow a…”
Get full text
Journal Article -
11
Population Pharmacokinetic and Pharmacodynamic Modeling of Epacadostat in Patients With Advanced Solid Malignancies
Published in Journal of clinical pharmacology (01-06-2017)“…Epacadostat (EPA, INCB024360) is a selective inhibitor of the enzyme indoleamine 2,3‐dioxygenase 1 (IDO1) and is being developed as an orally active…”
Get full text
Journal Article -
12
The relevance of assessment of intestinal P-gp inhibition using digoxin as an in vivo probe substrate
Published in Nature reviews. Drug discovery (01-01-2011)Get full text
Journal Article -
13
The Effect of CYP3A4 Inhibition or Induction on the Pharmacokinetics and Pharmacodynamics of Orally Administered Ruxolitinib (INCB018424 Phosphate) in Healthy Volunteers
Published in Journal of clinical pharmacology (01-06-2012)“…Ruxolitinib, a selective Janus kinase (JAK) 1&2 inhibitor in development for the treatment of myeloproliferative neoplasms, is primarily metabolized by CYP3A4…”
Get full text
Journal Article -
14
Micromechanical model for self-organized secondary phase oxide nanorod arrays in epitaxial YBa2Cu3O7−δ films
Published in Philosophical magazine (Abingdon, England) (11-08-2012)“…A micromechanical model based on the theory of elasticity has been developed to study the configuration of self-assembled secondary phase oxide nanostructures…”
Get full text
Journal Article -
15
Roles of UGT, P450, and Gut Microbiota in the Metabolism of Epacadostat in Humans
Published in Drug metabolism and disposition (01-10-2016)“…Epacadostat (EPA, INCB024360) is a first-in-class, orally active, investigational drug targeting the enzyme indoleamine 2,3-dioxygenase 1 (IDO1). In Phase I…”
Get full text
Journal Article -
16
Medical students’ experience of the hidden curriculum around primary care careers: a qualitative exploration of reflective diaries
Published in BMJ open (29-07-2021)“…ObjectivesPrimary healthcare internationally is facing a workforce crisis with fewer junior doctors choosing general practice (GP) as a career. In the UK, a…”
Get full text
Journal Article -
17
Preclinical Evaluation of Local JAK1 and JAK2 Inhibition in Cutaneous Inflammation
Published in Journal of investigative dermatology (01-09-2011)“…JAKs are required for signaling initiated by several cytokines (e.g., IL-4, IL-12, IL-23, thymic stromal lymphopoietin (TSLP), and IFNγ) implicated in the…”
Get full text
Journal Article -
18
Potential Underprediction of Warfarin Drug Interaction From Conventional Interaction Studies and Risk Mitigation: A Case Study With Epacadostat, an IDO1 Inhibitor
Published in Journal of clinical pharmacology (01-11-2016)“…Drug–drug interaction (DDI) studies involving warfarin are typically conducted with subtherapeutic doses of warfarin to ensure the safety of volunteers…”
Get full text
Journal Article -
19
Structural transition of secondary phase oxide nanorods in epitaxial YBa2Cu3O7−δ films on vicinal substrates
Published in Philosophical magazine (Abingdon, England) (01-12-2012)“…A theoretical study of a structural transition of secondary phase oxide nanorods in epitaxial YBa 2 Cu 3 O 7−δ films on vicinal SrTiO 3 substrates is…”
Get full text
Journal Article -
20
Construction of a two-parameter empirical model of left ventricle wall motion using cardiac tagged magnetic resonance imaging data
Published in Biomedical engineering online (24-10-2012)“…A one-parameter model was previously proposed to characterize the short axis motion of the LV wall at the mid-ventricle level. The single parameter of this…”
Get full text
Journal Article